GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $856,000 | -78.3% | 26,780 | -76.5% | 0.04% | -76.7% |
| Q1 2022 | $3,952,000 | +121.0% | 114,092 | +237.7% | 0.18% | +78.2% |
| Q1 2019 | $1,788,000 | +28.7% | 33,789 | -0.2% | 0.10% | -5.6% |
| Q4 2018 | $1,389,000 | +64.4% | 33,844 | +93.4% | 0.11% | +197.2% |
| Q1 2018 | $845,000 | -47.3% | 17,500 | -70.1% | 0.04% | -58.6% |
| Q2 2017 | $1,603,000 | +55.6% | 58,600 | -5.6% | 0.09% | +61.1% |
| Q2 2016 | $1,030,000 | – | 62,100 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |